FDA approves sorafenib for thyroid carcinoma

From the American Thyroid Association:
In collaboration with the Food and Drug Administration (FDA), and as a service to our members, ATA will provide updates on recent FDA approvals and other important FDA actions (e.g., updated safety information, new prescribing information) pertaining to therapies for cancer patients. Read More…